Concepedia

Molykutty John‐Aryankalayil

MJ

8

Publications

445

Citations

8

H-Index

2005

Active since

Affiliations

National Cancer Institute(Current)

Center for Cancer Research

GenUs BioSystems (United States)

National Institutes of Health

Molykutty John‐Aryankalayil is an author at National Cancer Institute specializing in medicine, cell biology, and tumor biology.

Top concepts

MedicineCell BiologyOncologyTumor BiologyCancer BiologyRadiation OncologyTumor MicroenvironmentPathologyRadiotherapyGene Expression

Publications per year

2005–2014

8

Publications

8

PX‐478, an inhibitor of hypoxia‐inducible factor‐1α, enhances radiosensitivity of prostate carcinoma cells

Sanjeewani T. Palayoor, James B. Mitchell, David Cerna et al. · International Journal of Cancer · 2008 · 126 citations · Full text

Pathology, Cancer Biology, Tumor Biology +17

Fractionated Radiation Alters Oncomir and Tumor Suppressor miRNAs in Human Prostate Cancer Cells

Molykutty John‐Aryankalayil, Sanjeewani T. Palayoor, Adeola Y. Makinde et al. · Radiation Research · 2012 · 75 citations

Urology, Systems Biology, Radiation Alters Oncomir +15

Microarray and protein analysis of human pterygium.

Molykutty John‐Aryankalayil, Nicholas Dushku, Cynthia Jaworski et al. · PubMed · 2006 · 60 citations

Fractionated Radiation Therapy Can Induce a Molecular Profile for Therapeutic Targeting

Molykutty John‐Aryankalayil, Sanjeewani T. Palayoor, David Cerna et al. · Radiation Research · 2010 · 57 citations

Fractionated Irradiation, Immunology, Radiation Biology +20

NS-398, ibuprofen, and cyclooxygenase-2 RNA interference produce significantly different gene expression profiles in prostate cancer cells

Molykutty John‐Aryankalayil, Sanjeewani T. Palayoor, David Cerna et al. · Molecular Cancer Therapeutics · 2009 · 41 citations · Full text

Rows per page

1–5 of 8